| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $13.0M | +132.2% |
| SG&A Expense | $3.2M | -2.3% |
| Operating Income | -$16.2M | -83.0% |
| Pre-tax Income | -$15.6M | -85.5% |
| Income Tax | $800 | +0.0% |
| Net Income | -$15.6M | -85.5% |
| EPS (Basic) | -$4.11 | -573.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.8M | +530.6% |
| Current Assets | $60.3M | +722.2% |
| Total Assets | $60.3M | +720.8% |
| Total Liabilities | $5.3M | +199.0% |
| Stockholders' Equity | $55.0M | +885.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.4M | +18.5% |
| Investing Cash Flow | -$14.3M | -391.0% |
| Financing Cash Flow | $59.3M | +2824.8% |